Seeking Alpha

Salix Pharma (SLXP): Q2 EPS of $0.32 misses by $0.12. Revenue of $133.1M (+43% Y/Y) beats by...

Salix Pharma (SLXP): Q2 EPS of $0.32 misses by $0.12. Revenue of $133.1M (+43% Y/Y) beats by $2M. Reaffirms FY11 Revenue guidance of $520M and PAT of $110M (excl. payments to Lupin). Shares +0.5% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector